Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Actoferrin is a patented oral tablet formulation of lactoferrin (100 mg) developed by Bennet Pharmaceuticals. The product utilizes proprietary SALT (Solid Absorption and Lipid Technology) to enhance the bioavailability of lactoferrin, a multifunctional iron-binding glycoprotein naturally found in milk and other secretions. Lactoferrin exhibits antimicrobial, antiviral, anti-inflammatory, and immunomodulatory properties, primarily by sequestering iron required for microbial growth and interacting with immune cell receptors to modulate inflammatory responses. While specific clinical trial phases for this formulation are not publicly detailed, it is positioned for therapeutic use in managing infections and supporting immune health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Actoferrin.